Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Lung fibrosis after bleomycin therapy]

J Kozielski1, R Rauer, D Ziora

  • 1Kliniki Ftizjopneumonologii Sl. AM, Zabrzu.

Pneumonologia I Alergologia Polska
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adipokines in interstitial lung diseases.

Respiratory physiology & neurobiology·2023
Same author

Physical Functioning and Symptoms of Chronic Fatigue in Sarcoidosis Patients.

Advances in experimental medicine and biology·2017
Same author

Predominance of Comorbidities in the Detriment of Daily Activity in Sarcoidosis Patients.

Advances in experimental medicine and biology·2017
Same author

Pulmonary Rehabilitation in Advanced Lung Cancer Patients During Chemotherapy.

Advances in experimental medicine and biology·2015
Same author

Serum omentin levels in adolescent girls with anorexia nervosa and obesity.

Physiological research·2015
Same author

Fatigue in sarcoidosis and exercise tolerance, dyspnea, and quality of life.

Advances in experimental medicine and biology·2014

This case study shows that high-dose corticosteroids can reverse lung damage caused by bleomycin therapy for malignant granulomatosis. Early intervention led to significant radiological, clinical, and functional improvements in a patient with lung fibrosis.

Area of Science:

  • Pulmonology
  • Oncology
  • Pharmacology

Background:

  • Malignant granulomatosis is a condition treated with chemotherapy agents like bleomycin.
  • Bleomycin therapy can cause interstitial pulmonary changes, a serious side effect.
  • Early identification and management of bleomycin-induced lung injury are crucial.

Observation:

  • A 44-year-old male undergoing bleomycin therapy for malignant granulomatosis developed interstitial pulmonary changes.
  • The patient presented with symptoms indicative of lung fibrosis.
  • Radiological, clinical, and functional assessments were performed.

Findings:

  • Introduction of high-dose corticosteroids led to observable improvement in the patient's condition.
  • Radiological imaging showed a reduction in pulmonary changes.

Related Experiment Videos

  • Clinical symptoms and pulmonary function tests demonstrated significant recovery over a 7-month treatment period.

    • Implications:

    • This case highlights the potential reversibility of bleomycin-induced lung injury with prompt corticosteroid treatment.
    • High-dose corticosteroids may be an effective therapeutic strategy for managing this adverse effect.
    • Further research into optimal treatment protocols for bleomycin-induced pulmonary toxicity is warranted.